Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Profdent Oy
OY
Active
Y-tunnus 2518957-5
Lh. 19, 20100
Turku
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2012 · 13 years old
0 employees
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Profdent Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
0M
2022
0M
2023
0M
2024
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2019
0M
0%
2020
0M
0%
2022
0M
0%
2023
0M
0%
2024
Income statement
EUR thousands
Item
2019
2020
2022
2023
2024
Revenue
1
14
4
3
1
Staff expenses
—
—
—
−0
−0
EBITDA
−6
10
4
−0
−8
Depreciation & amort.
−1
−1
−0
−0
−1
EBIT
−6
9
3
−1
−8
Net financials
−3
−2
−2
−2
−3
Profit before tax
−9
7
1
−2
−11
Tax
−0
−0
−0
−0
−0
Net profit
−9
7
1
−2
−11
Balance sheet
EUR thousands
Item
2019
2020
2022
2023
2024
Total assets
22
34
28
27
28
Equity
−71
−64
−63
−65
−76
Long-term debt
26
25
25
25
24
Short-term debt
67
73
66
66
80
Total debt
93
98
91
92
104
Financial ratios
5-year trend
EBITDA-margin
-983.7%
This company
15.8%
Market median
-6326% vs market
2019
2024
Soliditetsgrad
-271.8%
This company
38.2%
Market median
-812% vs market
2019
2024
Egenkapitalforrentning
-1086500.0%
This company
18.4%
Market median
-5904991% vs market
2019
2024
Nettoresultatgrad
-1382.3%
This company
8.1%
Market median
-17165% vs market
2019
2024
Aktivomsætning
0.03×
This company
1.12×
Market median
-97% vs market
2019
2024
Gæld/egenkapital
1.37×
This company
0.62×
Market median
-121% vs market
2019
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2023-06-01 – 2024-05-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-06-01 – 2023-05-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-06-01 – 2022-05-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2019-06-01 – 2020-05-31
View
PDF
Annual report 2019
Filed via PRH / YTJ · Period 2018-06-01 – 2019-05-31
View
PDF
More on Profdent Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
